Literature DB >> 12354999

Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.

Ali S Arbab1, Tomoaki Ichikawa, Hironobu Sou, Tsutomu Araki, Hiroto Nakajima, Keiichi Ishigame, Takeharu Yoshikawa, Hiroshi Kumagai.   

Abstract

PURPOSE: To investigate whether ferumoxides-enhanced double-echo T2-weighted magnetic resonance (MR) imaging alone can allow differentiation of metastases from benign lesions in the noncirrhotic liver.
MATERIALS AND METHODS: At retrospective review of files and images, 60 lesions (22 metastases, 20 hemangiomas, and 18 cysts) were identified in 42 patients. All fast spin-echo T2-weighted MR images obtained before and after administration of ferumoxides with short (80-90 msec) and long (180-250 msec) echo times (TEs) were acquired with a 1.5-T system. Differences in lesion-to-liver signal intensity ratio between images obtained with long and short TEs were calculated. Data from all 60 lesions were entered into a receiver operating characteristic analysis. Three independent readers scored their observations of each lesion with a confidence level of 1-5. The diagnostic accuracy of each analysis method was determined by calculating the area under each reader-specific receiver operating characteristic curve. Interobserver agreement was calculated with the use of chance-corrected kappa statistics. Relative sensitivity, specificity, and accuracy of characterizing benign lesions with each method were calculated.
RESULTS: Markedly low signal intensity and lesion-to-liver ratio on ferumoxides-enhanced images were observed with hemangioma. The difference of lesion-to-liver ratio between long and short TEs on ferumoxides-enhanced images was significantly different from that of unenhanced images and that of metastases or cysts. Interobserver agreement was good to excellent. Ferumoxides-enhanced images (with short and long TEs) showed significantly higher diagnostic accuracy than that of unenhanced images (with short or short and long TEs). Ferumoxides-enhanced images showed similar sensitivity, specificity, and accuracy when all images were reviewed together.
CONCLUSION: Ferumoxides-enhanced T2-weighted MR images appear useful in differentiating metastases from benign (nonsolid) lesions in the liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354999     DOI: 10.1148/radiol.2251011090

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

2.  Differentiation of hepatic tumors by use of image contrast with T2-weighted MRI.

Authors:  Akio Ogura; Katsumi Hayakawa; Tosiaki Miyati; Fumie Maeda; Akira Miyai; Fumito Saeki; Takaharu Murata
Journal:  Radiol Phys Technol       Date:  2008-11-11

3.  Resovist-enhanced MRI for preoperative assessment of colorectal hepatic metastases: a case of multiple bile duct hamartomas associated with colon cancer.

Authors:  Hiroshi Suzuki; Giichiro Tsurita; Soichiro Ishihara; Masaaki Akahane; Joji Kitayama; Hirokazu Nagawa
Journal:  Case Rep Gastroenterol       Date:  2008-12-10

4.  MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).

Authors:  Ali S Arbab; Adarsh Shankar; Nadimpalli R S Varma; Dorrah Deeb; Xiaohua Gao; A S M Iskander; Branislava Janic; Meser M Ali; Subhash C Gautam
Journal:  BMC Med Imaging       Date:  2011-12-13       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.